Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Therapy
Residual disease is associated with skin flap thickness after skin-sparing mastectomies
January 26th, 2006
Residual disease is associated with skin flap thickness >5mm after skin-sparing mastectomies. According to researchers writing in the Annals of Surgical Oncology, "The oncological safety of skin-sparing mastectomy (SSM) has been the object of several studies. From June 2003 to January 2004, 42 breast cancer patients, stage 0 to IIIA, underwent SSM. Before surgery, two lines were drawn on the breast skin, representing SSM and conventional mastectomy incisions." R.Z. Torresan and colleagues continued, "After surgery, the skin flap that would remain after SSM was removed, and immediate breast reconstruction was begun. The presence and amount...
Source: Women's Health Weekly (2006-01-26)
|
